CSLLY
Csl ADR

78
Mkt Cap
$48.38B
Volume
223,253.00
52W High
$44.86
52W Low
$24.42
PE Ratio
34.53
CSLLY Fundamentals
Price
$25.07
Prev Close
$24.92
Open
$24.65
50D MA
$28.34
Beta
0.70
Avg. Volume
373,730.11
EPS (Annual)
$1.55
P/B
2.58
Rev/Employee
$531,164.44
$87,722.37
Loading...
Loading...

About

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment provides plasma products, gene therapies, and recombinants. The CSL Seqirus segment includes predominantly influenza related products and provides pandemic services to governments. The CSL Vidor segment focuses on the distribution of products in the therapeutic areas of iron deficiency and nephrology. The company was founded on November 2, 1961 and is headquartered in Melbourne, Australia.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
29,000

Frequently Asked Questions

What is Market Cap of CSL Ltd. - ADR?
What is the 52-week high for CSL Ltd. - ADR?
What is the 52-week low for CSL Ltd. - ADR?
What is CSL Ltd. - ADR stock price today?
What was CSL Ltd. - ADR stock price yesterday?
What is the PE ratio of CSL Ltd. - ADR?
What is the Price-to-Book ratio of CSL Ltd. - ADR?
What is the 50-day moving average of CSL Ltd. - ADR?
How many employees does CSL Ltd. - ADR have?

Latest CSLLY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.